Folate-conjugated human serum albumin-encapsulated resveratrol nanoparticles: preparation, characterization, bioavailability and targeting of liver tumors

Resveratrol-loaded glycyrrhizic acid-conjugated human serum albumin nanoparticles wrapping resveratrol nanoparticles: Preparation, characterization, and targeting effect on liver tumors

(2017) Mingfang Wu et al.   JOURNAL OF BIOMATERIALS APPLICATIONS

Physagulide Q suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells by regulating the ROS-JAK2/Src-STAT3 signaling pathway

(2017) Yan-Wei Yang et al.   RSC Advances

Combined image guided monitoring the pharmacokinetics of rapamycin loaded human serum albumin nanoparticles with a split luciferase reporter

(2016) Fu Wang et al.   Nanoscale

Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death

(2016) R Venkatadri et al.   Cell Death & Disease

The prognostic value of serum LDH levels in patients with hepatocellualr carcinoma after hepatic resection

(2015) Wen-Jie Hu et al.   Anti-Cancer Agents in Medicinal Chemistry

Pitfalls of the MTT assay: Direct and off-target effects of inhibitors can result in over/underestimation of cell viability

(2015) A.A. Stepanenko et al.   GENE

Interest of preoperative immunonutrition in liver resection for cancer: study protocol of the PROPILS trial, a multicenter randomized controlled phase IV trial

(2015) Oriana Ciacio et al.   BMC CANCER

Delivery strategies for sustained drug release in the lungs

(2014) Cristina Loira-Pastoriza et al.   ADVANCED DRUG DELIVERY REVIEWS

Resveratrol and cancer: focus on in vivo evidence

(2014) Lindsay G Carter et al.   ENDOCRINE-RELATED CANCER

In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery

(2014) S. Jose et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Advances in ophthalmic drug delivery

(2014) Thakur Raghu Raj Singh et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells

(2013) Lingxia Tong et al.   ANTI-CANCER DRUGS

Treatment with resveratrol attenuates sublesional bone loss in spinal cord-injured rats

(2013) Hua-Dong Wang et al.   BRITISH JOURNAL OF PHARMACOLOGY

Optimization of an anti-HER2 monoclonal antibody targeted delivery system using PEGylated human serum albumin nanoparticles

(2013) Hasan Kouchakzadeh et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Acetal Derivatives as Prodrugs of Resveratrol

(2013) Andrea Mattarei et al.   MOLECULAR PHARMACEUTICS

PREPARATION OF FOLATE-CONJUGATED BOVINE SERUM ALBUMIN NANOPARTICLES ADSORBING EPIRUBICIN HYDROCHLORIDE

(2013) XIUHUA ZHAO et al.   NANO

Resveratrol: A multitargeted agent for age-associated chronic diseases

(2011) Kuzhuvelil B. Harikumar et al.   CELL CYCLE

Albumin-based nanoparticles as potential controlled release drug delivery systems

(2011) Ahmed O. Elzoghby et al.   JOURNAL OF CONTROLLED RELEASE

Limitation of the MTT and XTT assays for measuring cell viability due to superoxide formation induced by nano-scale TiO2

(2011) Shuguang Wang et al.   TOXICOLOGY IN VITRO

Erythropoietin Encapsulation in Chitosan Nanoparticles and Kinetics of Drug Release

(2011) M. Bokharaei et al.   Current Drug Delivery

Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells

(2010) Karsten Ulbrich et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Preparation and characterization of folate conjugatedN-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor:in vitrostudies

(2009) Yu Zheng et al.   JOURNAL OF DRUG TARGETING

Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS process

(2008) Jeong-Soo Kim et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles

(2008) Felix Kratz   JOURNAL OF CONTROLLED RELEASE